Cyclo Therapeutics Inc
General ticker "CYTH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.3M
Cyclo Therapeutics Inc does not follow the US Stock Market performance with the rate: -41.3%.
Estimated limits based on current volatility of 4.4%: low 0.59$, high 0.65$
Factors to consider:
- Current price 46.3% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.12$, 2.64$]
- 2024-12-30 to 2025-12-30 estimated range: [1.00$, 2.41$]
Short-term CYTH quotes
Long-term CYTH plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $1.08MM |
| Operating Expenses | $21.13MM |
| Operating Income | $-20.05MM |
| Non-Operating Income | $-0.01MM |
| R&D Expense | $14.18MM |
| Income(Loss) | $-20.06MM |
| Profit(Loss) | $-20.06MM |
| Stockholders Equity | $4.76MM |
| Inventory | $0.25MM |
| Assets | $13.25MM |
| Operating Cash Flow | $-16.19MM |
| Capital expenditure | $0.00MM |
| Investing Cash Flow | $-0.00MM |
| Financing Cash Flow | $23.89MM |
| Earnings Per Share* | $-1.23 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.